Nectar Laboratories Profile
Key Indicators
- Authorised Capital ₹ 9.50 Cr
as on 13-12-2024
- Paid Up Capital ₹ 9.40 Cr
as on 13-12-2024
- Company Age 30 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.85 Cr
as on 13-12-2024
- Revenue 18.21%
(FY 2023)
- Profit -37.10%
(FY 2023)
- Ebitda -22.91%
(FY 2023)
- Net Worth 15.68%
(FY 2023)
- Total Assets -14.24%
(FY 2023)
About Nectar Laboratories
The Corporate was formerly known as Nectar Laboratories Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 9.50 Cr and a paid-up capital of Rs 9.40 Cr.
The company has closed loans amounting to ₹5.85 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sunoj Mysore, Darla Prasad, and Veerraju Golla serve as directors at the Company.
- CIN/LLPIN
U65922TG1994PTC017176
- Company No.
017176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Nectar Laboratories Private Limited offer?
Nectar Laboratories Private Limited offers a wide range of products and services, including Common Disease Medicines, Hair Growth Medicine, Anti Infective Drugs & Medicines, Antifungal Cream, Ointment & Powder, Antibiotic Injection, Antibacterial Drugs.
Who are the key members and board of directors at Nectar Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunoj Mysore  | Director | 25-Apr-2022 | Current |
| Darla Prasad | Director | 02-Jun-2021 | Current |
| Veerraju Golla | Director | 19-Nov-2020 | Current |
Financial Performance of Nectar Laboratories.
Nectar Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.21% increase. The company also saw a substantial fall in profitability, with a 37.1% decrease in profit. The company's net worth Soared by an impressive increase of 15.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nectar Laboratories?
In 2023, Nectar Laboratories had a promoter holding of 84.92% and a public holding of 15.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Industrial Development Bank Of India Creation Date: 16 Aug 1996 | ₹4.30 M | Satisfied |
State Bank Of Hyderabad Creation Date: 22 Jul 1996 | ₹7.70 M | Satisfied |
State Bank Of Hyderabad Creation Date: 25 Sep 1995 | ₹7.50 M | Satisfied |
How Many Employees Work at Nectar Laboratories?
Unlock and access historical data on people associated with Nectar Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nectar Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nectar Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
